Amicus Curiae:	AARP, Alliance for Humane Biotechnology, Alnylam Pharmaceuticals, Inc., American Intellectual Property Law Association, Andrew Chin, Animal Health Institute, Asian Communities for Reproductive Justice, Association of University Technology Managers, BioGenerator, Biotechnology Industry Organization, Boston Patent Law Association, Burrill & Company, Canavan Foundation, Cancer Council Australia, Celera Corporation, Christopher M. Holman, Claire Altman Heine Foundation, Inc., Council for Responsible Genetics, CropLife International, E. Richard Gold, Elan Pharmaceuticals, Inc., Erika R. George, Facing Our Risk of Cancer Empowered, Federation Internationale Des Conseils en Propriete Indust, Friends of the Earth, Generations Ahead, Genetic Alliance, Genomic Health, Inc., George Mason University, Gilead Sciences, Inc., Greenpeace, Inc., Intellectual Property Owners Association, James P. Evans, Kali N. Murray, Kane Biotech Inc., Luigi Palombi, March of Dimes Foundation, Massachusetts Breast Cancer Coalition, Merial Limited, National Association for Pseudoxanthoma Elasticum, National Organization for Rare Disorders, National Tay-Sachs & Allied Diseases Association, Novartis Corporation, Ovarian Cancer National Alliance, Pharmaceutical Research and Manufacturers of America, Robert Cook-Deegan, Rosetta Genomics, Inc., Rosetta Genomics, Ltd., Tania Bubela, Target Discovery, Inc., The American College of Embryology, The American College of Obstetricians and Gynecologists, The American Medical Association, The American Society of Human Genetics, The Center for Genetics and Society, The Coalition for 21st Century Medicine, The Indigenous Peoples Counsel on Biocolonialism, The International Center for Technology Assessment, The Medical Society of the State of New York, The National Women's Health Network, The Pro-Choice Alliance for Responsible Research, The Southern Baptist Convention, United States, Universities Allied for Essential Medicines, University of New Hampshire School of Law, University of North Carolina School of Law and XDx, Inc.
Defendant-Appellant:	Arnold B. Combe, Director, University of Utah Research Foundation, David W. Pershing, Director, University of Utah Research Foundation, Jack Brittain, Director, University of Utah Research Foundation, James U. Jensen, Director, University of Utah Research Foundation, John Kendall Morris, Director, University of Utah Research Foundation, Lorris Betz, Director, University of Utah Research Foundation, Michael K. Young, Director, University of Utah Research Foundation, Myriad Genetics, Inc., Raymond Gesteland, University of Utah Research Foundation, Roger Boyer, Director, University of Utah Research Foundation and Thomas Parks, Director, University of Utah Research Foundation
Plaintiff-Appellee:	Arupa Ganguly, PhD, Boston Women's Health Book Collective, Breast Cancer Action, David Ledbetter, PhD, Ellen Matloff, M.S., Elsa Reich, M.S., Genae Girard, Haig Kazazian, MD, Harry Ostrer, MD, Kathleen Raker, Lisbeth Ceriani, Patrice Fortune, Runi Limary, Stephen Warren, PhD, The American College of Medical Genetics, The American Society for Clinical Pathology, The Association for Molecular Pathology, The College of American Pathologists, Vicky Thomason and Wendy Chung, MD, PhD
Case Number:	10-1406
Filed:	June 16, 2010
Court:	U.S. Court of Appeals, Federal Circuit
Nature of Suit:	Other

Access additional case information on PACER

Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.